Matthew D. Galsky, Joaquim Bellmunt, Charlene Mantia, Benjamin Garmezy, Gopa Iyer, Daniel P. Petrylak, Evisa Gjini, Adarsh Joshi, Yelena Mikhailov, Ani Nguyen, Bijal Kakrecha, Michael L. Meyers, Michaela Bowden, Matthew I. Milowsky, Xin Gao. "Updated clinical results and associated biomarkers from an ongoing phase 1 study of FX-909, a first-in-class peroxisome proliferator-activated receptor gamma (PPARG) inhibitor, in patients (pts) with advanced urothelial carcinoma (adv UC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.lba639